TNSN92063A1 - NOVEL METHOD FOR OBTAINING AN ANTI-GLAUCOMA COMPOSITION AND METHOD FOR OBTAINING IT - Google Patents

NOVEL METHOD FOR OBTAINING AN ANTI-GLAUCOMA COMPOSITION AND METHOD FOR OBTAINING IT

Info

Publication number
TNSN92063A1
TNSN92063A1 TNSN92063A TNSN92063A1 TN SN92063 A1 TNSN92063 A1 TN SN92063A1 TN SN92063 A TNSN92063 A TN SN92063A TN SN92063 A1 TNSN92063 A1 TN SN92063A1
Authority
TN
Tunisia
Prior art keywords
obtaining
glaucoma
composition
novel method
novel
Prior art date
Application number
Other languages
French (fr)
Inventor
Gerard Schwadrohn
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9109016A external-priority patent/FR2679138B1/en
Priority claimed from FR9109017A external-priority patent/FR2679139B1/en
Priority claimed from FR9109015A external-priority patent/FR2679137B1/en
Priority claimed from FR9110160A external-priority patent/FR2680108B1/en
Application filed by Theramex filed Critical Theramex
Publication of TNSN92063A1 publication Critical patent/TNSN92063A1/en

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

L'INVENTION SE RAPPORTE AU DOMAINE DE LA CHIMIE THERAPEUTIQUE. ELLE CONCERNE PLUS PARTICULIERMENT CELUI DE LA REALISATION DE COMPOSITIONS PHARMACEUTIQUES POUR L'APPLICATION OCULAIRE. ELLE A POUR OBJET UN PROCEDE D'OBTENTION DE COMPOSITION POUR L'APPLICATION OCULAIRE CARACTERISE EN CE QU'IL RENFERME AU MOINS UN COMPOSE DE STRUCTURE STEROIDIENNE SELECTIONNE, EN ASSOCIATION OU EN MELANGE AVEC UN EXCIPIENT OU UN VEHICULE INERTE PHARMACEUTIQUEMENT ACCEPTABLE. LES COMPOSITIONS SELON L'INVENTION S'ADRESSENT AU TRAITEMENT DU GLAUCOMETHE INVENTION RELATES TO THE FIELD OF THERAPEUTIC CHEMISTRY. IT CONCERNS MORE PARTICULARLY THAT OF THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR EYE APPLICATION. THE SUBJECT IS A PROCESS FOR OBTAINING A COMPOSITION FOR THE CHARACTERIZED EYE APPLICATION IN THAT IT CONTAINS AT LEAST ONE COMPOUND OF SELECTED STEROID STRUCTURE, IN ASSOCIATION OR IN MIXTURE WITH A PHARMACEUTICALLY ACCEPTABLE EXCIPIENT OR VEHICLE. COMPOSITIONS ACCORDING TO THE INVENTION ARE FOR THE TREATMENT OF GLAUCOMA

TNSN92063 1991-07-17 1992-07-16 NOVEL METHOD FOR OBTAINING AN ANTI-GLAUCOMA COMPOSITION AND METHOD FOR OBTAINING IT TNSN92063A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9109016A FR2679138B1 (en) 1991-07-17 1991-07-17 ANTI-GLAUCOMA PHARMACEUTICAL COMPOSITIONS AND THEIR PROCESS FOR OBTAINING SAME.
FR9109017A FR2679139B1 (en) 1991-07-17 1991-07-17 NOVEL PHARMACEUTICAL COMPOSITIONS FOR EYE APPLICATION CONTAINING AN ANDROSTENIC DERIVATIVE AND THEIR PREPARATION METHOD.
FR9109015A FR2679137B1 (en) 1991-07-17 1991-07-17 NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON A PREGNENIC DERIVATIVE AND THEIR PREPARATION METHOD.
FR9110160A FR2680108B1 (en) 1991-08-09 1991-08-09 NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON 6-HYDROXYMETHYL STEROUIDES AND PROCESS FOR OBTAINING SAME.

Publications (1)

Publication Number Publication Date
TNSN92063A1 true TNSN92063A1 (en) 1993-06-08

Family

ID=27446812

Family Applications (1)

Application Number Title Priority Date Filing Date
TNSN92063 TNSN92063A1 (en) 1991-07-17 1992-07-16 NOVEL METHOD FOR OBTAINING AN ANTI-GLAUCOMA COMPOSITION AND METHOD FOR OBTAINING IT

Country Status (4)

Country Link
DZ (1) DZ1600A1 (en)
IE (1) IE922252A1 (en)
MA (1) MA22592A1 (en)
TN (1) TNSN92063A1 (en)

Also Published As

Publication number Publication date
DZ1600A1 (en) 2002-02-17
MA22592A1 (en) 1993-04-01
IE922252A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
PH24814A (en) Method of increasing tear production by topical administration of cyclosporin
ATE153855T1 (en) COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA CONTAINING PROSTAGLANDINS AND CLONIDINE DERIVATIVES
CA2059403A1 (en) Use of Carrageenans in Topical Ophthalmic Compositions
FR2679446B1 (en) METHOD FOR MANUFACTURING A COSMETIC COMPOSITION FOR APPLICATION TO HAIR, COMPOSITION OBTAINED BY THIS PROCESS AND METHOD FOR COSMETIC TREATMENT USING THE SAME.
FI902258A0 (en) Process for the preparation of pharmacologically active 13,14-dihydro-17-phenyl-18,19,20-trinor-PGF2 alkyl esters
TR27463A (en) Non-irritating tooth composition.
IL120317A0 (en) Otic antibacterial compositions
RU94042240A (en) Activated amino acid receptor antagonists, preparation process, intermediate compounds, pharmaceutical composition
CA1070615A (en) Veterinary compositions of semi-synthetic penicillin
HUT56351A (en) Process for producing pharmaceutical compositions for reducing eye pressure
FR2554346B1 (en) ASSEMBLY AND METHOD FOR THE DELIVERY OF GANGLIOSIDES AND THEIR DERIVATIVES BY INHALATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN97164A1 (en) NOVEL HORMONAL COMPOSITION AND ITS USE
TNSN92063A1 (en) NOVEL METHOD FOR OBTAINING AN ANTI-GLAUCOMA COMPOSITION AND METHOD FOR OBTAINING IT
US5200180A (en) Pharmaceutical composition for the treatment of the human eye
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
DE69331235T2 (en) BENZOYLECGONINE, ECGONINE AND ECGONIDINE DERIVATIVES AS MEDICINAL PRODUCTS
HUP0003803A2 (en) Use of flunarizine for producing pharmaceutical compositions useful for the topical treating of glaucoma
KR950702422A (en) Ophthalmic topical composition (S) -TIMOLOL HEMIHYDRATE containing (S) -timolol hemihydrate
DE3362246D1 (en) Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle
US3780176A (en) Predominantly aqueous substituted triamcinolone compositions
HUT56559A (en) Process for producing ascorbinic acid derivatives and pharma
RU1216844C (en) Method of stimulating rut of cattle
DE69914937T2 (en) BETABLOCKER AND CARBOPOL CONTAINING OPHTALMIC COMPOSITION
EP0019720A2 (en) Mesulfen preparations and method of making them
RU94003002A (en) Method of prolongation of thymolol therapeutic action